Prozkoumejte nejčtenější články a videa na Campus Sanofi
Real-life safety and effectiveness outcomes of teriflunomide in patients with relapsing–remitting multiple sclerosis: The TERICAM study Martínez-Ginés ML, et al. Neurology Perspectives. 2023;100133.